Interim financial report, Q1 2007/08

 | Source: Coloplast A/S Coloplast A/S 

Coloplast generated 11% organic growth in the first quarter, reinforcing its
position as the world s leading supplier of intimate healthcare products. The
company retains the full-year earnings forecast, but lowers its forecast for
organic growth exclusively because of weaker revenue flows in the German
healthcare business HSC. In DKK-terms, both revenue and earnings will be
affected by exchange rate developments. 
See the full announcement in the enclosed PDF.

Attachments

2008_q1_18_feb final version gb.pdf
GlobeNewswire

Recommended Reading